EN
Product
  • Product
  • News

MicroPort Successfully Performed First TrueForce™ Case in Overseas Market

2023-11-02 16:44:00      Views:

Izmir, Turkey——On 27th of October, Dr. Emin from Dokuz Eylul University-Heart Rhythm Management Center has successfully performed 2 AF procedures and 1 AFL procedure utilizing FireMagic™ TrueForce™ Ablation Catheter (referred to TrueForce™ Ablation Catheter) and the latest Columbus™ 3D EP Navigation System (referred to Columbus™ System). It marked the official launch of TrueForce™ Ablation Catheter in overseas market.

 

During the procedure, Dr. Emin has highly praised TrueForce™ Ablation Catheter. He said that the catheter features precise measurement of contact force and high maneuverability. The distance measuring function enables precise positioning of SmartLabel site, reducing the probability of GAP occurrence and contributing to the safety and efficacy of ablation procedures greatly. He also appreciated the new features of Columbus™ latest software. When comparing TrueForce™ Ablation Catheter’s moving process between Columbus™ latest software and X-ray, the precision and real-time displaying of RTM modelling gained his recognition. The first successful clinical applications of TrueForce™ Ablation Catheter marks official launch in overseas market.

 

The TrueForce™ Ablation Catheter is the first cardiac RF ablation catheter incorporating force-sensing technology in China. When seamlessly integrated with the Columbus™3D EP Navigation system, they can provide active measurement of catheter-tissue contact force and catheter tip direction, calculate Energy Index (EI) based on key ablation parameters related to lesion formation in real-time, to achieve successful ablation. The catheter was CE marked and UKCA marked on August of 2023.

 

To date, MicroPort EP products have been exported to more than 30 countries, in future, MicroPort EP will continue to build a differentiated product portfolio and expand its global reach, offering comprehensive solutions for diagnosis and therapy of EP interventions to more patients and doctors worldwide.

Share:
Tel:
(86)(21)60969600
Add:  Building 28, Lane 588, Tianxiong Road. Shanghai, P. R. China
©Copyright 2023, Shanghai MicroPort EP MedTech Co., Ltd. All rights reserved.
Website License Number:Shanghai ICP Record No.16034362

Internet Drug Information Service Qualification Certificate Number: (Shanghai) - non operational - 2016-0126

  • Home
  • Tel
  • Top